Company: PolyPid Ltd.
Ticker: Nasdaq: PYPD
Sector: Healthcare
Investor Contact: Ben Shamsian

PolyPid News

News

PolyPid to Present D-PLEX Microbiology Data at IDWeek 2026

Analysis demonstrates a lower bacterial burden in breakthrough surgical-site infections, with similar proportions of multidrug-resistant organisms between treatment groupsPETACH TIKVA, Israel, Oct. 21, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or...

PolyPid to Host Virtual Investor Day on Wednesday, October 28, 2026

Management to outline 'PolyPid 2030', the Company's long-term vision and pipeline strategy Event to feature Warren S. Joseph, DPM, FIDSA, a nationally recognized specialist in lower extremity infectious diseases Petach Tikva, Israel, Oct. 15, 2026 (GLOBE NEWSWIRE) --...

PolyPid Announces Participation in Upcoming Fall Investor Conferences

PETACH TIKVA, Israel, Sept. 15, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today...

Skip to content